author-photo

Bryan Li

Queen Mary Hospital

5

Papers

10

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

The use of cabozantinib in advanced hepatocellular carcinoma (HCC): Hong Kong multi-center experience.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Randomized phase II trial of sorafenib, capecitabine and oxaliplatin (SECOX) versus single agent sorafenib in patients with advanced hepatocellular carcinoma.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Outcomes of tyrosine kinase inhibitors (TKI) after immunotherapy in unresectable or advanced hepatocellular carcinoma (HCC) patients.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)